Horizon Therapeutics Plc
(NASDAQ : HZNP)

( )
HZNP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -5.30%47.500.0%$315.64m
VRXValeant Pharmaceuticals International, Inc. 1.46%28.4814.1%$167.58m
HZNPHorizon Therapeutics Plc -0.06%112.885.5%$128.25m
ICLRICON plc 0.37%277.582.8%$116.38m
CTLTCatalent, Inc. 2.25%133.332.0%$102.51m
JAZZJazz Pharmaceuticals Plc 2.59%144.002.1%$96.03m
PRGOPerrigo Co. Plc 1.97%45.656.9%$75.29m
UTHRUnited Therapeutics Corp. 1.11%186.3614.0%$64.99m
ARGXargenx SE 1.25%295.580.0%$53.06m
GRVIGrove, Inc. 23.83%7.640.0%$45.69m
BHCBausch Health Cos., Inc. 1.46%28.480.0%$44.12m
AXSMAxsome Therapeutics, Inc. -2.29%40.181.8%$41.11m
PCRXPacira Biosciences, Inc. -1.06%52.529.8%$32.16m
ENDPEndo International Plc 1.20%4.218.5%$32.03m
IRWDIronwood Pharmaceuticals, Inc. 0.22%13.449.5%$24.26m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.